GBA1 and Parkinson disease: Importantly, even heterozygous carriers of GBA1 mutations—who typically do not manifest GD—have elevated risk for PD and DLB, which indicates that partial GCase deficiency (or dysfunction) in the brain is sufficient to modify risk of synucleinopathy [11].